PhillyDeals: Effort to market female-pleasure remedy meets resistance
Rachel Braun Scherl and her business partner, Mary Wallace-Jaensch, veteran drug marketers, were looking for a new idea two years ago when they found Zestra Laboratories Inc., a South Carolina company floundering in federal bankruptcy court in Wilmington.
Rachel Braun Scherl
and her business partner,
Mary Wallace-Jaensch
, veteran drug marketers, were looking for a new idea two years ago when they found
Zestra Laboratories Inc.
, a South Carolina company floundering in federal bankruptcy court in Wilmington.
Zestra sold an ointment made of evening-primrose oil and other old-time plant remedies that, when applied to women's intimate parts, enhanced sexual pleasure.
It boasted studies from a dozen U.S. commercial contract research labs claiming the stuff works. It is registered and regulated - not under strict federal drug guidelines, but as a cosmetic.
To Scherl and Jaensch, given the potential market of millions of women, this was a no-brainer.
"This business came across our desks, and we thought, 'How hard can this be?' " Scherl told me. The women financed Zestra's bankruptcy reorganization and refounded the company as Semprae Laboratories Inc., with offices in Saddle Brook, N.J.
They persuaded Ira Lubert's Philadelphia-based Quaker BioVentures Inc., whose clients include the state of Pennsylvania's retirement plans, to invest $2.5 million in Semprae, for the purpose of expanded marketing.
Quaker partner Adele Oliva joined the board of Semprae as chairwoman. Stacie Mullen, marketing executive at Horsham diet-food vendor NutriSystem Inc., and Lucinda Duncalfe-Holt, who has headed a string of venture capital-backed software-makers in the region, also took board seats.
Since then, Scherl says, 75,000 women have bought Zestra online and at Wal-Mart, Rite Aid, and other discount stores. But the owners have had a tough time getting support from doctors.
"The medical health community is really opposed to medicalizing" female sexual satisfaction problems and calling it a disease, Scherl said.
Why the different standard? "Male anatomy is a hydraulic system. Plug the blood in, it works. Women's is so much more complex," says Scherl. "It has psychological elements, physical elements, behavioral elements, social or contextual elements. . . . When I ask focus groups, 'What's great sex?' women give 100 different answers."
The company also has a tough time buying TV ads. CBS and NBC initially rejected Zestra's soft-sell ads, Scherl says. "ABC said we could only air during Jimmy Kimmel." ESPN, which runs penile-enhancement ads, told Zestra's buyers it made exceptions for those products when the advertisers are NASCAR sponsors. So Semprae weighed an offer to become a NASCAR sponsor, too.
"It's OK for Viagra or Cialis to discuss an erection in their ads," said Beth Bronfman, chief executive of New York ad agency Leibler Bronfman Lubalin Corp., which represents Zestra. "But we haven't been able to clear this, and nobody will give us a reason. If we were Johnson & Johnson, I don't think we'd have this double standard. But they are not used to this product category yet."
I can't personally tell you if this stuff works. When I asked the question - purely hypothetically - to the only woman I'm licensed to have sexual relations with, she said, "No way. We've already got six children."
I asked her to run it by her gynecologist, a hard-boiled woman recommended to her by the doctor and nurse who delivered our twins. My wife, who loves her gyno, called back to recount her reaction: " 'For women, sexual desire is mental. People already spend too much money on sex,' and then she went on and on, complaining about Obamacare."
























